NO995030L - 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister - Google Patents

5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister

Info

Publication number
NO995030L
NO995030L NO995030A NO995030A NO995030L NO 995030 L NO995030 L NO 995030L NO 995030 A NO995030 A NO 995030A NO 995030 A NO995030 A NO 995030A NO 995030 L NO995030 L NO 995030L
Authority
NO
Norway
Prior art keywords
imidazolinylamino
alpha
adrenoceptor agonists
compounds useful
benzimidazole compounds
Prior art date
Application number
NO995030A
Other languages
English (en)
Norwegian (no)
Other versions
NO995030D0 (no
Inventor
Thomas Lee Cupps
Sophie Eva Bogdan
Glen Edward Mieling
Nick Nikolaides
Raymond Todd Henry
Russell James Sheldon
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO995030D0 publication Critical patent/NO995030D0/no
Publication of NO995030L publication Critical patent/NO995030L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO995030A 1997-04-15 1999-10-15 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister NO995030L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4231697P 1997-04-15 1997-04-15
PCT/IB1998/000540 WO1998046595A1 (fr) 1997-04-15 1998-04-09 Composes de 5-(2-imidazolinylamino)benzimidazole utiles en tant qu'agonistes de l'adrenorecepteur alpha-2

Publications (2)

Publication Number Publication Date
NO995030D0 NO995030D0 (no) 1999-10-15
NO995030L true NO995030L (no) 1999-12-15

Family

ID=21921202

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995030A NO995030L (no) 1997-04-15 1999-10-15 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister

Country Status (12)

Country Link
EP (1) EP0975627A1 (fr)
JP (1) JP2001519828A (fr)
KR (1) KR20010006440A (fr)
CN (1) CN1256691A (fr)
AU (1) AU6514498A (fr)
BR (1) BR9808904A (fr)
CA (1) CA2285610A1 (fr)
HU (1) HUP0002242A2 (fr)
ID (1) ID24081A (fr)
IL (1) IL132384A0 (fr)
NO (1) NO995030L (fr)
WO (1) WO1998046595A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004270A1 (fr) 1994-08-04 1996-02-15 Synaptic Pharmaceutical Corporation Nouveaux derives de benzimidazole
US6495583B1 (en) 1997-03-25 2002-12-17 Synaptic Pharmaceutical Corporation Benzimidazole derivatives
WO1999026942A1 (fr) * 1997-11-24 1999-06-03 The Procter & Gamble Company 5-(2-imidazolinylamino)-benzimidazole, derives et procedes de preparation et d'utilisation de ces derniers en tant qu'agonistes du recepteur alpha-adrenergique ayant une meilleure stabilite metabolique
US20040167194A1 (en) * 2003-02-20 2004-08-26 Randall Jared Lynn Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form
US8555875B2 (en) 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN110540523B (zh) * 2018-07-05 2021-02-19 安徽圣诺贝化学科技有限公司 一种制备磺基取代苯并咪唑及其衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
WO1996004270A1 (fr) * 1994-08-04 1996-02-15 Synaptic Pharmaceutical Corporation Nouveaux derives de benzimidazole

Also Published As

Publication number Publication date
JP2001519828A (ja) 2001-10-23
NO995030D0 (no) 1999-10-15
HUP0002242A2 (hu) 2001-04-28
WO1998046595A1 (fr) 1998-10-22
BR9808904A (pt) 2005-02-22
IL132384A0 (en) 2001-03-19
EP0975627A1 (fr) 2000-02-02
AU6514498A (en) 1998-11-11
CA2285610A1 (fr) 1998-10-22
CN1256691A (zh) 2000-06-14
KR20010006440A (ko) 2001-01-26
ID24081A (id) 2000-07-06

Similar Documents

Publication Publication Date Title
BR9811774A (pt) Tetraidroprostaglandinas aromáticas substituìdas por c16-c20 úteis como agonistas fp
BR9713542A (pt) Compostos de 2 - imidazolinilaminoindol úteis como agonistas do alfa - 2 - adrenoceptor
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
NO20000572D0 (no) Indolderivater som MCP-1 reseptor antagonister
TR200000673T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
TR200000670T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
DK1309544T3 (da) Forbindelser, der virker som melanocortinreceptorligander
DK0687251T3 (da) 1,3-dihydroindol-2-on-derivater, der er substitueret i 3-stillingen med en nitrogengruppe, til anvendelse som vasopressin- og/eller ocytocin-agonister og/eller -antagonister
IL146564A0 (en) Phenoxypropylamine derivatives and pharmaceutical compositions containing the same
NO20023161L (no) Substituerte piperidiner, legemidler inneholdende disse forbindelser og fremgangsmåter for fremstilling av dem
CA2272640A1 (fr) Composes guanidinyl heterocycles convenant comme agonistes de l&#39;adrenorecepteur alpha-2
NO20050612L (no) Pyrrolidinderivater som oksytocinantagonister
NO20060718L (no) Substituerte tiofoner og deres anvendelse
BR0008716A (pt) Inibidores de metaloprotease contendo alquenil ou alquinil
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
NO995030L (no) 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som &lt;alfa&gt;-2-adrenoseptoragonister
NO20014241L (no) C16-umettede FP-selektive prostaglandinanaloger
ES2202156T3 (es) Nuevos analogos de 2-descarboxi-2-fosfinico prostaglandina f.
NO974115L (no) Nye aminoalkanfosfinsyrer og deres salter
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
NO20065696L (no) Piperazinderivater av alkyloksindoler som 5-HT7 reseptoraktive midler.
BR9909268A (pt) C11 oximil e hidroxilamino prostaglandinas úteis como agonistas de fp
MX2023002068A (es) Nuevos compuestos que tienen actividad inhibidora sobre el receptor de prostaglandina e2 y usos de los mismos.
NO992502L (no) 2-Imidazolinylaminoindazolforbindelser nyttige som &lt;alfa&gt;-2 adrenerge reseptoragonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application